RetinalGenix Technologies (RTGN) Accounts Payables (2020 - 2026)

RetinalGenix Technologies has disclosed Accounts Payables across 7 years of filings, most recently posting $1.2 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $1.2 million, up 28.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 28.83% YoY), and the FY2025 annual result was $1.1 million, up 17.64% from the prior year.
• Accounts Payables came in at $1.2 million for Q1 2026 at RetinalGenix Technologies, up from $1.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.2 million in Q1 2026 to a low of $262467.0 in Q1 2022.
• The 5-year median for Accounts Payables is $862453.0 (2024), against an average of $773379.6.
• Across the five-year window, Accounts Payables surged 141.62% in 2023 and increased 4.2% in 2024, its largest moves.
• RetinalGenix Technologies' Accounts Payables stood at $475480.0 in 2022, then jumped by 86.11% to $884920.0 in 2023, then grew by 4.2% to $922083.0 in 2024, then grew by 17.64% to $1.1 million in 2025, then grew by 9.66% to $1.2 million in 2026.
• The last three Accounts Payables figures came in at $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.